Sight Sciences, Inc. recently announced it has received Health Canada approval for the VISCO™360 Viscosurgical System, which is indicated in Canada for the microcatheterization and transluminal viscodilation of Schlemm's canal to reduce intraocular pressure (IOP) in adult patients with open-angle glaucoma.
The VISCO360 System is reportedly a fully-integrated, single-handed, single-use device that offers a single-incision, 360-degree canal procedure. The system combines a custom access cannula, a soft and flexible microcatheter with an atraumatic tip, an internal infusion pump, gear mechanism, and viscoelastic reservoir, and a wheel that controls advancement and retraction of the microcatheter using only a single finger.
Click here to read the full press release.
Like what you read? Follow OphthalmologyWeb to keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.
Source: Sight Sciences, Inc.